. 2019 Feb 14;62(7):3254–3267. doi: 10.1021/acs.jmedchem.8b01719

Table 1. Inhibition of HCV Replicons for Approach A (9–11) and Comparator Compounds^a.

See Supporting Information for assay details, number of replicates, 95% confidence intervals, and cellular toxicity data (CC₅₀). Confidence intervals were derived from a pooled standard deviation (SD) calculated for each assay in log space (i.e., pEC₅₀), where replicates are normally distributed; pooled assay SDs are supplied parenthetically in the following notes.

GT 1b WT (SD = 0.21 log units) and 316N (SD = 0.24 log units) assays used a stable replicon system, whereas GT 1a WT (SD = 0.23 log units) and 316Y (SD = 0.20 log units) were transiently transfected.

Data originally reported in ref (8).

Data generated from a closely related assay system.

Not tested.

Table 1. Inhibition of HCV Replicons for Approach A (9–11) and Comparator Compoundsa.

Table 1. Inhibition of HCV Replicons for Approach A (9–11) and Comparator Compounds^a.